YARW

Yarrow Bioscience, Inc. - Common Stock (YARW)

About Yarrow Bioscience, Inc. - Common Stock (YARW)

Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.

Details

Daily high

$42.48

Daily low

$40.94

Price at open

$41.92

52 Week High

$44.28

52 Week Low

$7.91

Market cap

110.5M

Dividend yield

Volume

17,633

Avg. volume

29,305

P/E ratio

-1.76

Yarrow Bioscience, Inc. - Common Stock News